What is the requirement for submitting a “Sequence Listing XML” in international applications under the PCT?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
According to MPEP 2414.05, international applications filed under the PCT that contain a disclosure of nucleotide and/or amino acid sequences must include a sequence listing part of the description that complies with the standard provided in Annex C of the Administrative Instructions. The MPEP states:
“Where an international application, filed under the PCT, contains a disclosure of nucleotide and/or amino acid sequences, the description shall include a sequence listing part of the description complying with the standard provided for in Annex C of the Administrative Instruction.”
This requirement ensures that sequence information is provided in a standardized format for efficient processing and examination.